Recursion Pharmaceuticals
RXRX
#5082
Rank
โ‚ฌ1.60 B
Marketcap
2,57ย โ‚ฌ
Share price
3.86%
Change (1 day)
-28.35%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2026 (TTM): -0,78ย โ‚ฌ

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,82ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,35ย โ‚ฌ an increase over its 2024 EPS that were of -1,51ย โ‚ฌ.

EPS history for Recursion Pharmaceuticals from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,78ย โ‚ฌ-41.99%
2025-1,35ย โ‚ฌ-10.84%
2024-1,51ย โ‚ฌ5.73%
2023-1,43ย โ‚ฌ14.6%
2022-1,25ย โ‚ฌ17.39%
2021-1,06ย โ‚ฌ